- Oberarzt
- Facharzt für Urologie
- Medikamentöse Tumortherapie
Fachgebiete
-
Urologie
Tätigkeitsschwerpunkte
-
Rekonstruktive Urologie/Harnröhrenchirurgie, Uroonkologie
Mitgliedschaften
Publikationen
Long-term functional success and patient-reported outcomes after female one-stage buccal mucosal graft urethroplasty
Actas urologicas espanolas. 2024 [Epub ahead of print].
Urinary bladder transplantation in humans - current status and future perspectives
Czarnogórski M, Koper K, Petrasz P, Vetterlein M, Pokrywczyńska M, Juszczak K, Drewa T, Adamowicz J
NAT REV UROL. 2024 [Epub ahead of print].
Ultrasound imaging of male urethral stricture disease: a narrative review of the available evidence, focusing on selected prospective studies
Frankiewicz M, Vetterlein M, Markiet K, Adamowicz J, Campos-Juanatey F, Cocci A, Rosenbaum C, Verla W, Waterloos M, Mantica G, Matuszewski M
WORLD J UROL. 2024;42(1):32.
Update Harnleiterrekonstruktion 2024
Hook S, Gross A, Netsch C, Becker B, Filmar S, Vetterlein M, Kluth L, Rosenbaum C
UROLOGE. 2024;63(1):25-33.
Diagnostik und Therapie von Harnröhrenstrikturen – Leitlinienübersicht 2024: Teil 1 – anteriore Harnröhre
Klemm J, Dahlem R, Kluth L, Rosenbaum C, Shariat S, Fisch M, Vetterlein M
UROLOGE. 2024;63(1):3-14.
Diagnostik und Therapie von Harnröhrenstrikturen – Leitlinienübersicht 2024: Teil 2 – posteriore Harnröhre
Klemm J, Dahlem R, Kluth L, Rosenbaum C, Shariat S, Fisch M, Vetterlein M
UROLOGE. 2024;63(1):15-24.
P084 - Delineating functional outcomes and patient-reported treatment satisfaction after perineal urethrostomy as last resort management of complex anterior urethral strictures: Abstracts EAU24 - 39th Annual EAU Congress
Klemm J, Dahlem R, König F, Shariat S, Marks P, Fisch M, Vetterlein M
EUR UROL. 2024;85(S1):S109-S110.
Continent Diversion is Losing its Momentum:: a Nationwide Trend Analysis from Germany 2005-2021
Klemm J, Fisch M, Laukhtina E, Dahlem R, Shariat S, Vetterlein M
BJU INT. 2024;133(2):154-157.
Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy
Klemm J, Shariat S, Laukhtina E, Rajwa P, Vetterlein M, Schuettfort V, von Deimling M, Dahlem R, Fisch M, Rink M
CLIN GENITOURIN CANC. 2024;22(3):.
Female non-obstetric urogenital fistula repair: long-term patient-reported outcomes and a scoping literature review
Klemm J, Stelzl D, Schulz R, Marks P, Shariat S, Fisch M, Dahlem R, Vetterlein M
BJU INT. 2024;134(3):407-415.
P082 - Short-term morbidity and long-term functional outcomes of the T-plasty for salvage reconstruction of recalcitrant bladder neck stenosis: Abstracts EAU24 - 39th Annual EAU Congress
König F, Dahlem R, Marks P, Kühnke L, Klemm J, Fisch M, Vetterlein M
EUR UROL. 2024;85(1):S107.
Harnableitungen mit oder ohne simple Zystektomie in der Salvage-Therapie benigner Erkrankungen des unteren Harntraktes
Lutz M, Le Q, Müller M, Müller S, Rosenbaum C, Vetterlein M, Kluth L
UROLOGE. 2024;63(1):34-42.
Genital Art in the 21st Century: Piercings and Tattoos. The EAU YAU Reconstructive Urology Working Party Point of View
Mantica G, Frankiewicz M, Verla W, Waterloos M, Vetterlein M, Van der Merwe A, Ralph D, Cocci A
ARCH ESP UROL. 2024;77(7):837-838.
Advancing Intraoperative Assessment of Urethral Stricture Anatomic Variation: a Prospective Proof-of-concept Study
Marks P, Dahlem R, Daniels P, Klemm J, Kühnke L, Kranzbühler B, König F, Ding L, Engel O, Soave A, Fisch M, Vetterlein M
UROL INT. 2024;108(3):254-258.
Controversies of Mucosa and Spongiosum Preservation in Non-Transecting Augmented Anastomotic Repair
Marks P, Dahlem R, Fisch M, Vetterlein M
BJU INT. 2024;133(3):351-352.
Expertise Area 2.2: Rare diseases and conditions affecting the female urethra
Medina-Polo J, Vetterlein M, Klemm J
2024. Rare and Complex Urology. Feitz W, Tidman J (Hrsg.). 1. Aufl. San Diego: Academic Press, 183-193.
P115 - Why underrepresentation costs lives: First results from a high-volume multi-institutional study in Germany about risk factors for mortality in Fournier gangrene: Abstracts EAU24 - 39th Annual EAU Congress
Rieger C, Hübers M, Pfister D, Schleifer S, Hirsch J, Kranz J, Gerdes B, Pantea V, Chachin A, Träger M, Glienke M, Henniges P, Vetterlein M, Klemm J, Roghmann F, Dellino M, Jany U, Tylingr M, Al Assali K, Patroi P, Mayr R, Engelmann S, Schneidewind L, Heidenreich A
EUR UROL. 2024;85(S1):S160-S161.
P175 - What do patients with Peyronie’s disease expect from therapy? A prospective multi-center study: Abstracts EAU24 - 39th Annual EAU Congress
Schaefer L, Cremers J, Witschel B, Schuettfort V, Nieder T, Koenig F, Vetterlein M, Gild P, Dahlem R, Fisch M, Kliesch S, Soave A
EUR UROL. 2024;85(S1):S247.
What do patients with Peyronie's disease expect from therapy?: A prospective multi-center study
Schäfer L, Cremers J, Witschel B, Schüttfort V, Nieder T, König F, Vetterlein M, Gild P, Dahlem R, Fisch M, Kliesch S, Soave A
ANDROLOGY-US. 2024;12(4):821-829.
Patient-reported outcomes after one-stage neourethral reconstruction in transmen with phalloplasty-associated strictures and fistulas
Schuettfort V, Graf R, Vetterlein M, Ludwig T, Gild P, Marks P, Soave A, Dahlem R, Fisch M, Riechardt S
WORLD J UROL. 2024;42(1):.
Evidenzbasierte Medizin in der rekonstruktiven Urologie
Vetterlein M, Rosenbaum C, Kluth L
UROLOGE. 2024;63(1):1-2.
Expertise Area 2.3: Urethral reconstruction in rare diseases and complex conditions
Vetterlein M, Wyndaele M, Campos-Juanatey F, Klemm J, de Kort L, Fisch M, Graaf P, Brits T, De Win G
2024. Rare and Complex Urology. Feitz W, Tidman J (Hrsg.). 1. Aufl. Oxford: Academic Press, 195-203.
Impact of the Extent of Lymph Node Dissection on Survival Outcomes in Clinically Lymph Node-Positive Bladder Cancer
von Deimling M, Furrer M, Mertens L, Mari A, van Ginkel N, Bacchiani M, Maas M, Pichler R, Li R, Moschini M, Bianchi A, Vetterlein M, Lonati C, Crocetto F, Taylor J, Tully K, Afferi L, Soria F, Del Giudice F, Longoni M, Laukhtina E, Antonelli A, Rink M, Fisch M, Lotan Y, Spiess P, Black P, Kiss B, Pradere B, Shariat S
BJU INT. 2024;133(3):341-350.
Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, Schuettfort V, König F, Gild P, Ludwig T, Marks P, Dahlem R, Fisch M, Shariat S, Vetterlein M
CLIN GENITOURIN CANC. 2024;22(2):336-346.e9.
Urethral management after artificial urinary sphincter explantation due to cuff erosion
Białek Ł, Frankiewicz M, Adamowicz J, Campos-Juanatey F, Cocci A, Mantica G, Rosenbaum C, Verla W, Waterloos M, Vetterlein M
CENT EUR J UROL. 2023;76(4):322-324.
A Systematic Review on Postoperative Antibiotic Prophylaxis after Pediatric and Adult Male Urethral Reconstruction
Białek Ł, Rydzińska M, Vetterlein M, Dobruch J, Skrzypczyk M
J CLIN MED. 2023;12(19):.
The impact of surgical volume on perioperative safety after urethroplasty: the EAU YAU Reconstructive Urology Working Party point of view
Chierigo F, Mantica G, Adamowicz J, Campos-Juanatey F, Cocci A, Frankiewicz M, Rosenbaum C, Verla W, Waterloos M, Vetterlein M
MINERVA UROL NEPHROL. 2023;75(4):537-539.
Nephrometry and cumulative morbidity after partial nephrectomy: A standardized assessment of complications in the context of PADUA and R.E.N.A.L. scores
Filipas D, Yu H, Spink C, Rink M, Riechardt S, Gild P, Marks P, Fisch M, Dahlem R, Meyer C, Vetterlein M
UROL ONCOL-SEMIN ORI. 2023;41(1):51.e1-51.e11.
'Case of the Month' from University Medical Center Hamburg-Eppendorf, Germany: Vulvar cancer after female-male gender reassignment
Finger A, Riechardt S, Dahlem R, Soave A, Rink M, Sauter G, Contreras H, Steinhilper L, Fisch M, Vetterlein M, Schuettfort V
BJU INT. 2023;131(6):685-688.
VR, reconstructive urology and the future of surgery education
Frankiewicz M, Vetterlein M, Matuszewski M
NAT REV UROL. 2023;20(6):325-326.
Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP)
Gild P, Vetterlein M, Daoud I, Ludwig T, Soave A, Marks P, Chun F, Ahyai S, Dahlem R, Fisch M, Rink M, Meyer C, Becker A
J ENDOUROL. 2023;37(3):316-322.
MP78-09 SALVAGE DIRECT VISION INTERNAL URETHROTOMY FOR AFTER FAILED SUBSTITUTION URETHROPLASTY: EXTENDED LONG-TERM FOLLOW-UP FROM A RECONSTRUCTIVE REFERRAL CENTER
K. F, Roland D, Phillip M, A. L, Silke R, Margit F, W. V
J UROLOGY. 2023;209(Supplement 4):e1135.
MP64-16 THE EFFECT OF INDETERMINATE PATHOLOGIC MARGINS ON SURVIVAL AFTER SURGERY FOR RENAL CELL CARCINOMA
K. F, V. S, RINK M, Edoardo B, Muhieddine L, S. V, W. V, Mara K, Nicola F, P. C, Quoc-Dien T
J UROLOGY. 2023;209(Supplement 4):e887.
Reply to Marc A. Furrer and Patrick Y. Wuethrich's and Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, and Alberto Briganti's Letters to the Editor re: Jakob Klemm, Michael Rink, Markus Von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005
Klemm J, Koelker M, Shariat S, Fisch M, Vetterlein M
EUR UROL FOCUS. 2023 [Epub ahead of print].
Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting
Klemm J, Rink M, von Deimling M, Koelker M, Gild P, Shariat S, Dahlem R, Fisch M, Vetterlein M
EUR UROL FOCUS. 2023;9(6):1072-1076.
Rational peri-operative management of antithrombotic therapy in patients undergoing radical cystectomy: A 30-day morbidity analysis based on the updated European Association of Urology guidelines for standardized complication reporting
Koelker M, Bradtke M, Klemm J, von Deimling M, Gild P, Dahlem R, Fisch M, Rink M, Vetterlein M
EJSO-EUR J SURG ONC. 2023;49(12):107123.
Mucomucosal anastomotic non-transecting augmentation (MANTA) urethroplasty: a ventral modification for obliterative strictures
Marks P, Dahlem R, Janisch F, Klemm J, Kühnke L, König F, Ding L, Riechardt S, Fisch M, Vetterlein M
BJU INT. 2023;132(4):444-451.
Treatment Success After Urethroplasty: The Ongoing Quest for a Pragmatic and Universal Definition
Verla W, Mantica G, Waterloos M, Adamowicz J, Frankiewicz M, Cocci A, Rosenbaum C, Campos-Juanatey F, Vetterlein M
EUR UROL FOCUS. 2023;9(4):617-620.
Predefined and Standardized Complication Catalogs: An Essential Tool to Assess Reproducible Estimates of Overall Morbidity After Urological Surgery
Vetterlein M, Leyh-Bannurah S
J ENDOUROL. 2023;37(10):1166-1167.
Re: NIHR Global Research Health Unit on Global Surgery. Routine Sterile Glove and Instrument Change at the Time of Abdominal Wound Closure to Prevent Surgical Site Infection (ChEETAh): A Pragmatic, Cluster-randomised Trial in Seven Low-income and Middle-income Countries. Lancet 2022;400:1767-76
Vetterlein M, Trinh Q, Seisen T
EUR UROL. 2023;83(6):e158.
Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, König F, Gild P, Khonsari M, Ludwig T, Marks P, Dahlem R, Fisch M, Vetterlein M
BJU INT. 2023;131(1):90-100.
Outcomes and Complication Rates of Cuff Downsizing in the Treatment of Worsening or Persistent Incontinence After Artificial Urinary Sphincter Implantation
Weis S, Ludwig T, Bahassan O, Gild P, Vetterlein M, Fisch M, Dahlem R, Maurer V
INT NEUROUROL J. 2023;27(2):139-145.
Anesthetic Technique (Spinal vs. General Anesthesia) in Holmium Laser Enucleation of the Prostate: Retrospective Analysis of Procedural and Functional Outcomes among 1,159 Patients
Yu H, Gild P, Pompe R, Vetterlein M, Ludwig T, Soave A, Kölker M, Maurer V, Marks P, Becker A, Punke M, Fisch M, Rink M, Dahlem R, Meyer C
UROL INT. 2023;107(4):336-343.
Contemporary Management of Male Anterior Urethral Strictures by Reconstructive Urology Experts-Results from an International Survey among ESGURS Members
Campos-Juanatey F, Fes-Ascanio E, Adamowicz J, Castiglione F, Cocci A, Mantica G, Rosenbaum C, Verla W, Vetterlein M, Waterloos M, Kluth L
J CLIN MED. 2022;11(9):.
Urethroscopic Findings Following Urethroplasty Predict the Need for Secondary Intervention in the Long Term: A Multi-Institutional Study from Trauma and Urologic Reconstructive Network of Surgeons. Letter
Frankiewicz M, Cocci A, Vetterlein M, Verla W, Campos-Juanatey F, Castiglione F, Mantica G, Rosenbaum C, Waterloos M, Adamowicz J, Kluth L
J UROLOGY. 2022;208(5):957-958.
Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis
Kachanov M, Vetterlein M, Soave A, Karakiewicz P, Liakos N, Jankowski T, Pose R, Mandrek M, Fisch M, Witt J, Graefen M, Leyh-Bannurah S
AGING MALE. 2022;25(1):54-61.
Operative Versorgung von Harnröhrenverletzungen nach pelvinen Traumata
Klemm J, Marks P, Dahlem R, Riechardt S, Fisch M, Vetterlein M
UROLOGE. 2022;61(6):602-608.
Case - Salvage nerve-sparing radical cystectomy for pediatric rhabdomyosarcoma of the bladder
Klemm J, Rink M, Riechardt S, Stiel C, Büscheck F, Sauter G, Dahlem R, Fisch M, Vetterlein M
CUAJ-CAN UROL ASSOC. 2022;16(11):E575-E578.
Re: Christopher Soliman, Niranjan J. Sathianathen, Gianluca Giannarini, et al. There is a Need for a Universal Language in the Reporting and Grading of Complication and Intervention Events to Ensure Comparability and Improvement of Surgical Care. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.022
Koelker M, Rink M, Vetterlein M
EUR UROL. 2022;81(6):e150-e151.
Urethral Stricture Formation Following Cuff Erosion of AMS Artificial Urinary Sphincter Devices: Implication for a Less Invasive Explantation Approach
Kuhlencord K, Dahlem R, Vetterlein M, Abrams-Pompe R, Maurer V, Meyer C, Riechardt S, Fisch M, Ludwig T, Marks P
FRONT SURG. 2022;9:.
Urethral fixation to improve urinary continence recovery after radical cystectomy with ileal neobladder: the EAU YAU Reconstructive Working Party point of view
Mantica G, Cocci A, Vetterlein M, Verla W, Campos-Juanatey F, Castiglione F, Rosenbaum C, Waterloos M, Adamowicz J, Frankiewicz M, Kluth L
MINERVA UROL NEPHROL. 2022;74(3):365-367.
Reaching Consensus for Comprehensive Outcome Measurement After Urethral Stricture Surgery: Development of Study Protocol for Stricture-Fecta Criteria
Mantica G, Verla W, Cocci A, Frankiewicz M, Adamowicz J, Campos-Juanatey F, Rosenbaum C, Waterloos M, Kluth L, Vetterlein M
RES REP UROL. 2022;14:423-426.
Penile Flap Inversion Vaginoplasty in Transgender Women: Contemporary Morbidity and Learning-Curve Analysis From a High-Volume Reconstructive Center
Maurer V, Howaldt M, Feldmann I, Ludwig T, Vetterlein M, Gild P, Weis S, Marks P, Soave A, Meyer C, Fisch M, Dahlem R, Riechardt S
FRONT SURG. 2022;9:.
Reporting and grading of complications for intracorporeal robot-assisted radical cystectomy: An in-depth short-term morbidity assessment using the novel Comprehensive Complication Index®
Mendrek M, Witt J, Sarychev S, Liakos N, Addali M, Wagner C, Karagiotis T, Schuette A, Soave A, Fisch M, Reinisch J, Herrmann T, Vetterlein M, Leyh-Bannurah S
WORLD J UROL. 2022;40(7):1679-1688.
Precision-Guidance vs. Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious mpMRI Lesions
Rachubinski P, Witt J, Budäus L, Zinke J, Fangmeyer B, Spieker T, Vetterlein M, Rahbar K, Kachanov M, Leyh-Bannurah S
J UROLOGY. 2022;208(6):1203-1213.
Reply by Authors
Rachubinski P, Witt J, Budäus L, Zinke J, Fangmeyer B, Spieker T, Vetterlein M, Rahbar K, Kachanov M, Leyh-Bannurah S
J UROLOGY. 2022;208(6):1213.
Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center
Sarychev S, Witt J, Wagner C, Oelke M, Schuette A, Liakos N, Karagiotis T, Mendrek M, Kachanov M, Graefen M, Vetterlein M, Meyer C, Tian Z, Leyh-Bannurah S
WORLD J UROL. 2022;40(6):1419-1425.
Urinary Diversion With or Without Concomitant Cystectomy for Benign Conditions: A Comparative Morbidity Assessment According to the Updated European Association of Urology Guidelines on Reporting and Grading of Complications
Vetterlein M, Buhné M, Yu H, Klemm J, von Deimling M, Gild P, Koelker M, Dahlem R, Fisch M, Soave A, Rink M
EUR UROL FOCUS. 2022;8(6):1831-1839.
Assessing the Outcome of Holmium Laser Enucleation of the Prostate by Age, Prostate Volume, and a History of Blood Thinning Agents: Report from a Single-Center Series of >1800 Consecutive Cases
Gild P, Lenke L, Pompe R, Vetterlein M, Ludwig T, Soave A, Chun F, Ahyai S, Dahlem R, Fisch M, Rink M, Meyer C, Becker A
J ENDOUROL. 2021;35(5):639-646.
Outcome groups and a practical tool to predict success of shock wave lithotripsy in daily clinical routine
Hirsch B, Abt D, Güsewell S, Langenauer J, Betschart P, Pratsinis M, Vetterlein M, Schmid H, Wildermuth S, Zumstein V
WORLD J UROL. 2021;39(3):943-951.
Harnröhrenstrikturen der Frau: Aktuelles zu Diagnostik und Therapie
Kühnke L, Fisch M, Vetterlein M
AKTUEL UROL. 2021;52(3):260-267.
Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database
Maurer V, Stahlberg J, Schiffmann I, Marks P, Rosenbaum C, Soave A, Vetterlein M, Meyer C, Riechardt S, Fisch M, Ludwig T, Dahlem R
UROL INT. 2021;105(3-4):225-231.
Vesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapy
Pfalzgraf D, Worst T, Kranz J, Steffens J, Salomon G, Fisch M, Reiß C, Vetterlein M, Rosenbaum C
WORLD J UROL. 2021;39(1):89-95.
Evaluation of lymphovascular invasion as a prognostic predictor of overall survival after radical prostatectomy
Rakic N, Jamil M, Keeley J, Sood A, Vetterlein M, Dalela D, Arora S, Modonutti D, Bronkema C, Novara G, Peabody J, Rogers C, Menon M, Abdollah F
UROL ONCOL-SEMIN ORI. 2021;39(8):495.e1-495.e6.
Contemporary Outcomes after Transurethral Procedures for Bladder Neck Contracture Following Endoscopic Treatment of Benign Prostatic Hyperplasia
Rosenbaum C, Vetterlein M, Fisch M, Reiss P, Worst T, Kranz J, Steffens J, Kluth L, Pfalzgraf D
J CLIN MED. 2021;10(13):.
Learning benefits of live surgery and semi-live surgery in urology-informing the debate with results from the International Meeting of Reconstructive Urology (IMORU) VIII
Schuettfort V, Ludwig T, Marks P, Vetterlein M, Maurer V, Fuehner C, Janisch F, Soave A, Rink M, Riechardt S, Engel O, Fisch M, Dahlem R, Meyer C
WORLD J UROL. 2021;39(7):2801-2807.
Update on the management of penile and meatal strictures
Vetterlein M, Fisch M, Zumstein V
CURR OPIN UROL. 2021;31(5):493-497.
Exploring the intersection of functional recurrence, patient-reported sexual function, and treatment satisfaction after anterior buccal mucosal graft urethroplasty
Vetterlein M, Gödde A, Zumstein V, Gild P, Marks P, Soave A, Meyer C, Riechardt S, Dahlem R, Fisch M, Kluth L
WORLD J UROL. 2021;39(9):3533-3539.
Nomenclature and treatment of secondary urethral strictures following primary hypospadias repair: weighing up academic principles and clinical pragmatism
Vetterlein M, Zumstein V, Kluth L, Riechardt S, Dahlem R, Fisch M
WORLD J UROL. 2021;39(12):4513–4515.
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
Dobé T, Califano G, von Rundstedt F, Ouzaid I, Albisinni S, Aziz A, Di Trapani E, Hendricksen K, Krajewski W, Mari A, Moschini M, Necchi A, Noon A, Poyet C, Pradère B, Rink M, Roghmann F, Sargos P, Seiler R, Soria F, Vetterlein M, Xylinas E
EUR UROL OPEN SCI. 2020;22:45-50.
Longitudinal Evaluation of Perineogenital Pain and Postoperative Complications After One-stage Buccal Mucosal Graft Urethroplasty: A Secondary Analysis of a Randomized Controlled Trial
Fuehner C, Vetterlein M, Lesske J, Rink M, Riechardt S, König F, Gild P, Pinnschmidt H, Meyer C, Ludwig T, Engel O, Fisch M, Dahlem R, Soave A
EUR UROL FOCUS. 2020;7(5):1157-1165.
Retrograde Ejaculation After Holmium Laser Enucleation Of The Prostate (HoLEP) - Impact On Sexual Function and Evaluation Of Patient Bother Using Validated Questionnaires
Gild P, Dahlem R, Pompe R, Soave A, Vetterlein M, Ludwig T, Maurer V, Marks P, Ahyai S, Chun F, Lenke L, Ernst T, Fisch M, Rink M, Meyer C, Becker A
ANDROLOGY-US. 2020;8(6):1779-1786.
The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group
Gild P, Vetterlein M, Seiler R, Necchi A, Hendricksen K, Mertens L, Roghmann F, Landenberg N, Gontero P, Cumberbatch M, Dobruch J, Seisen T, Grande P, D'Andrea D, Anract J, Comploj E, Pycha A, Saba K, Poyet C, van Rhijn B, Noon A, Roupret M, Shariat S, Fisch M, Xylinas E, Rink M
SURG ONCOL. 2020;34:312-317.
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases
Gontero P, Pisano F, Palou J, Joniau S, Albersen M, Colombo R, Briganti A, Pellucchi F, Faba O, van Rhijn B, van de Putte E, Babjuk M, Fritsche H, Mayr R, Albers P, Niegisch G, Anract J, Masson-Lecomte A, De la Taille A, Roupret M, Peyronnet B, Cai T, Witjes A, Bruins M, Baniel J, Mano R, Lapini A, Sessa F, Irani J, Brausi M, Stenzl A, Karnes J, Scherr D, O'Malley P, Taylor B, Shariat S, Black P, Abdi H, Matveev V, Samuseva O, Parekh D, Gonzalgo M, Vetterlein M, Aziz A, Fisch M, Catto J, Pang K, Xylinas E, Rink M
WORLD J UROL. 2020;38(8):1959-1968.
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort
Janisch F, Hillemacher T, Fuehner C, D'Andrea D, Meyer C, Klotzbücher T, Kienapfel C, Vetterlein M, Kimura S, Abufaraj M, Dahlem R, Shariat S, Fisch M, Rink M
UROL ONCOL-SEMIN ORI. 2020;38(9):739.e9-739.e15.
Impact of Cardiovascular and Metabolic Risk Factors on Stricture Recurrence After Anterior One-stage Buccal Mucosal Graft Urethroplasty
Meyer C, Lamp J, Vetterlein M, Soave A, Engel O, Dahlem R, Fisch M, Kluth L
UROLOGY. 2020;146:253-259.
The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy
Rink M, Riethdorf S, Yu H, Kölker M, Vetterlein M, Dahlem R, Fisch M, Pantel K, Soave A
J CLIN MED. 2020;9(11):.
Contemporary Management of Vesico-Urethral Anastomotic Stenosis After Radical Prostatectomy
Rosenbaum C, Fisch M, Vetterlein M
FRONT SURG. 2020;7:587271.
Fistelchirurgie
Rosenbaum C, Vetterlein M, Fisch M
UROLOGE. 2020;59(4):489-498.
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
Soave A, Kluwe L, Yu H, Rink M, Gild P, Vetterlein M, Marks P, Sauter G, Fisch M, Meyer C, Ludwig T, Dahlem R, Minner S, Pantel K, Steinbach B, Schwarzenbach H
SCI REP-UK. 2020;10(1):21562.
Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size
Tully K, Moschini M, von Rundstedt F, Aziz A, Kluth L, Necchi A, Rink M, Hendricksen K, Sargos P, Vetterlein M, Seiler R, Poyet C, Krajewski W, Fajkovic H, Shariat S, Xylinas E, Roghmann F
UROL ONCOL-SEMIN ORI. 2020;38(11):851.e19-851.e25.
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer
Vetterlein M, Gild P, Fisch M, Rink M
EUR UROL. 2020;78(2):e77-e78.
Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index
Vetterlein M, Klemm J, Gild P, Bradtke M, Soave A, Dahlem R, Fisch M, Rink M
EUR UROL. 2020;77(1):55-65.
Buccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM)
Vetterlein M, Kluth L, Zumstein V, Meyer C, Ludwig T, Soave A, Riechardt S, Engel O, Dahlem R, Fisch M, Rosenbaum C
WORLD J UROL. 2020;38(11):2863-2872.
Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.08.011: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting
Vetterlein M, Rink M
EUR UROL. 2020;77(1):e12-e13.
Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future
Vetterlein M, Witjes J, Loriot Y, Giannarini G, Albersen M, Ribal M, Rouprêt M
EUR UROL ONCOL. 2020;3(6):789-801.
Is Standardization Transferable? Initial Experience of Urethral Surgery at the University Hospital Frankfurt
Wenzel M, Krimphove M, Lauer B, Hoeh B, Müller M, Mandel P, Becker A, Vetterlein M, Mueller S, Dahlem R, Fisch M, Chun F, Kluth L
FRONT SURG. 2020;7:600090.
A critical outcome analysis of Asopa single-stage dorsal inlay substitution urethroplasty for penile urethral stricture
Zumstein V, Dahlem R, Kluth L, Rosenbaum C, Maurer V, Bahassan O, Engel O, Fisch M, Vetterlein M
WORLD J UROL. 2020;38(5):1283-1294.
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S, D'Andrea D, Vetterlein M, Cole A, Fletcher S, Krimphove M, Marchese M, Lipsitz S, Sonpavde G, Noldus J, Shariat S, Kibel A, Trinh Q, Mossanen M
CANCER-AM CANCER SOC. 2019;125(9):1449-1458.
Current Therapies of Wilms Tumors in the Adult: Diagnostic Considerations and Treatment Challenges
Bradtke M, Rink M, Büscheck F, Sauter G, Dahlem R, Fisch M, Vetterlein M
CLIN GENITOURIN CANC. 2019;17(3):e522-e525.
Update on managing anterior urethral strictures
Fühner C, Dahlem R, Fisch M, Vetterlein M
INDIAN J UROL. 2019;35(2):94-100.
Do Younger Patients With Muscle-invasive Bladder Cancer Have Better Outcomes?
Janisch F, Yu H, Vetterlein M, Dahlem R, Engel O, Fisch M, Shariat S, Soave A, Rink M
J CLIN MED. 2019;8(9):.
The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy
Marks P, Gild P, Soave A, Janisch F, Minner S, Engel O, Vetterlein M, Shariat S, Sauter G, Dahlem R, Fisch M, Rink M
SURG ONCOL. 2019;28:208-213.
Distal Double Cuff Vs. Transcorporal Cuff as Salvage Options - a Prospective Analysis of Different Artificial Urinary Sphincter (AMS 800) Implantation Sites
Maurer V, Dahlem R, Rosenbaum C, Gild P, Vetterlein M, Schüttfort V, Meyer C, Riechardt S, Fisch M, Marks P, Ludwig T
UROLOGY. 2019;133:234-239.
The current role of circulating biomarkers in non-muscle invasive bladder cancer
Rink M, Schwarzenbach H, Vetterlein M, Riethdorf S, Soave A
TRANSL ANDROL UROL. 2019;8(1):61-75.
The impact of surgical sequence on outcome rates of artificial urinary sphincter implantation: comparative effectiveness of primary, secondary and repeat implantation
Rosenbaum C, Pham T, Dahlem R, Maurer V, Marks P, Vetterlein M, Fisch M, Ludwig T
WORLD J UROL. 2019 [Epub ahead of print].
Feedback eines Patienten
Rosenbaum C, Vetterlein M
Uro-News. 2019;23(10):14-17.
Reply: Letter-to-the-editor: Direct Vision Internal Urethrotomy for short anterior urethral strictures and Beyond: Success Rates, Predictors of Treatment Failure and Recurrence Management
Rosenbaum C, Vetterlein M, Kluth L
UROLOGY. 2019;124(313):313.
Live surgery in reconstructive urology: evaluation of the surgical outcome and educational benefit of the international meeting on reconstructive urology (IMORU)
Schuettfort V, Schoof J, Rosenbaum C, Ludwig T, Vetterlein M, Leyh-Bannurah S, Maurer V, Meyer C, Dahlem R, Fisch M, Reiss C
WORLD J UROL. 2019;37(11):2533-2539.
Negative Self-Perception and Self-Attitude of Sexuality Is a Risk Factor for Patient Dissatisfaction Following Penile Surgery with Small Intestinal Submucosa Grafting for the Treatment of Severe Peyronie's Disease
Soave A, Laurich S, Dahlem R, Vetterlein M, Engel O, Nieder T, Briken P, Rink M, Fisch M, Reiss C
J CLIN MED. 2019;8(8):.
Awareness and perception of multidrug-resistant organisms and antimicrobial therapy among internists vs. surgeons of different specialties: Results from the German MR2 Survey
Spachmann P, May M, Vetterlein M, Fritsche H, Steffen S, Schostak M, Wagenlehner F, Burger M, Weylandt K, Salzberger B, Brookman-May S, Gilfrich C
CASP J INTERN MED. 2019;10(2):132-141.
Characterization of a Standardized Postoperative Radiographic and Functional Voiding Trial after 1-Stage Bulbar Ventral Onlay Buccal Mucosal Graft Urethroplasty and the Impact on Stricture Recurrence-Free Survival
Vetterlein M, Loewe C, Zumstein V, Rosenbaum C, Engel O, Dahlem R, Fisch M, Kluth L
J UROLOGY. 2019;201(3):563-572.
Surgical Reconstruction of Posterior Urethral Complications Following Prostate Cancer Treatments
Vetterlein M, Rosenbaum C, Fisch M
2019 [Epub ahead of print]. Textbook of Male Genitourethral Reconstruction. Martins F, Kulkarni S, Köhler T (Hrsg.). Cham: Springer International Publishing, 303-317.
Anterior Urethral Strictures in Children: Disease Etiology and Comparative Effectiveness of Endoscopic Treatment vs. Open Surgical Reconstruction
Vetterlein M, Weisbach L, Riechardt S, Fisch M
FRONT PEDIATR. 2019;7:5.
Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
Zumstein V, Betschart P, Vetterlein M, Kluth L, Hechelhammer L, Mordasini L, Engeler D, Kessler T, Schmid H, Abt D
EUR UROL FOCUS. 2019;5(6):1091-1100.
Single-stage buccal mucosal graft urethroplasty for meatal stenoses and fossa navicularis strictures: a monocentric outcome analysis and literature review on alternative treatment options
Zumstein V, Dahlem R, Maurer V, Marks P, Kluth L, Rosenbaum C, Ludwig T, Meyer C, Riechardt S, Engel O, Fisch M, Vetterlein M
WORLD J UROL. 2019 [Epub ahead of print].
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer
BJU INT. 2018;121(1):101-110.
The effect of treatment at minority-serving hospitals on outcomes for bladder cancer
Fletcher S, Gild P, Cole A, Vetterlein M, Kibel A, Choueiri T, Sonpavde G, Preston M, Pucheril D, Menon M, Sun M, Lipsitz S, Trinh Q
UROL ONCOL-SEMIN ORI. 2018;36(5):238.e7-238.e17.
Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study
Gierth M, Zeman F, Denzinger S, Vetterlein M, Fisch M, Bastian P, Syring I, Ellinger J, Müller S, Herrmann E, Gilfrich C, May M, Pycha A, Wagenlehner F, Vallo S, Bartsch G, Haferkamp A, Grimm M, Roigas J, Protzel C, Hakenberg O, Fritsche H, Burger M, Aziz A, Mayr R
UROL INT. 2018;101(1):16-24.
Adult iatrogenic ureteral injury and stricture – incidence and treatment strategies
Gild P, Kluth L, Vetterlein M, Engel O, Chun F, Fisch M
ASIAN J UROL. 2018;5(2):101-106.
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA
Hanna N, Trinh Q, Seisen T, Vetterlein M, Sammon J, Preston M, Lipsitz S, Bellmunt J, Menon M, Choueiri T, Abdollah F
EUR UROL ONCOL. 2018;1(1):83-90.
Re: Letter to the editor
Lebentrau S, Gilfrich C, Vetterlein M, Schumacher H, Spachmann P, Brookman-May S, Fritsche H, Schostak M, Wagenlehner F, Burger M, May M
INT UROL NEPHROL. 2018;50(5):875.
Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis
Seisen T, Vetterlein M, Karabon P, Jindal T, Sood A, Nocera L, Nguyen P, Choueiri T, Trinh Q, Menon M, Abdollah F
EUR UROL. 2018;73(3):452–461.
Re: Vetterlein et al.: State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update (Urology 2018;112:56-65) Reply
Vetterlein M, Abdollah F
UROLOGY. 2018;116:232-233.
State-by-State Variation in Prostate-Specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update
Vetterlein M, Dalela D, Sammon J, Karabon P, Sood A, Jindal T, Meyer C, Löppenberg B, Sun M, Trinh Q, Menon M, Abdollah F
UROLOGY. 2018;112:56-65.
Evaluating Guideline Adherence for T1 Bladder Cancer Treatment and Surveillance: A Retrospective German Multicenter Observation
Vetterlein M, Gild P, Marks P, Roschinski J, Doh O, Höppner W, Wagner W, Isbarn H, Büscheck F, Sauter G, Dahlem R, Soave A, Fisch M, Rink M
UROL INT. 2018;101(3):285-292.
Impact of Baseline Characteristics on the Survival Benefit of High-Intensity Local Treatment in Metastatic Urothelial Carcinoma of the Bladder
Vetterlein M, Karabon P, Dalela D, Jindal T, Sood A, Seisen T, Trinh Q, Menon M, Abdollah F
EUR UROL FOCUS. 2018;4(4):568-571.
Robot-Assisted Laparoscopic Radical Prostatectomy in Patients with Clinically High-Risk Prostate Cancer
Vetterlein M, Menon M, Abdollah F
2018. Robotics in Genitourinary Surgery. Hemal A, Menon M (Hrsg.). Cham: Springer International Publishing, 363-373.
EDITORIAL COMMENT REPLY
Vetterlein M, Sammon J, Abdollah F
UROLOGY. 2018;112:64-65.
Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer
Vetterlein M, Seisen T, Leow J, Preston M, Sun M, Friedlander D, Meyer C, Chun F, Lipsitz S, Menon M, Kibel A, Bellmunt J, Choueiri T, Trinh Q
CLIN GENITOURIN CANC. 2018;16(1):e129-e139.
The Impact of Surgical Sequence on Stricture Recurrence after Anterior 1-Stage Buccal Mucosal Graft Urethroplasty: Comparative Effectiveness of Initial, Repeat and Secondary Procedures
Vetterlein M, Stahlberg J, Zumstein V, Engel O, Dahlem R, Fisch M, Rosenbaum C, Kluth L
J UROLOGY. 2018;200(6):1308-1314.
Meatusenge und glanduläre Harnröhrenstriktur
Zeller S, Vetterlein M, Fisch M, Kluth L
UROLOGE. 2018;57(1):11-16.
Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer
Dulz S, Asselborn N, Dieckmann K, Matthies C, Wagner W, Weidmann J, Seidel C, Oing C, Berger L, Alsdorf W, Mankichian B, Meyer C, Vetterlein M, Gild P, Ludwig T, Soave A, Schriefer P, Becker A, Ahyai S, Oechsle K, Bokemeyer C, Wagenfeld L, Fisch M, Hartmann M, Chun F, Kluth L
J CANCER RES CLIN. 2017;143(7):1319-1325.
Racial disparities in prostate cancer treatment—does facility level make a difference?
Gild P, Vetterlein M, Meyer C, Schmid M, Chun F
J XiangYa Med. 2017;2(16):1-2.
Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis
Grimmig T, Moll E, Kloos K, Thumm R, Moench R, Callies S, Kreckel J, Vetterlein M, Pelz J, Polat B, Tripathi S, Rehder R, Ribas C, Chandraker A, Germer C, Waaga-Gasser A, Gasser M
Cancer Growth and Metastasis. 2017;(10):1179064417730559.
Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses
Jindal T, Kachroo N, Sammon J, Dalela D, Sood A, Vetterlein M, Karabon P, Jeong W, Menon M, Trinh Q, Abdollah F
UROL ONCOL-SEMIN ORI. 2017;35(7):460.e9-460.e20.
Direct Vision Internal Urethrotomy for Short Anterior Urethral Strictures and Beyond: Success Rates, Predictors of Treatment Failure and Recurrence Management
Kluth L, Ernst L, Vetterlein M, Meyer C, Reiss C, Fisch M, Rosenbaum C
UROLOGY. 2017;106:210-215.
Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship
Lebentrau S, Gilfrich C, Vetterlein M, Schumacher H, Spachmann P, Brookman-May S, Fritsche H, Schostak M, Wagenlehner F, Burger M, May M
INT UROL NEPHROL. 2017;49(8):1311-1318.
The Urologist's Role in Antibiotic Stewardship: Results from the MR2 Study
Lebentrau S, Vetterlein M, May M
EUR UROL. 2017;71(6):995-996.
Variation in Locoregional Prostate Cancer Care and Treatment Trends at Commission on Cancer Designated Facilities: A National Cancer Data Base Analysis 2004 to 2013
Löppenberg B, Sood A, Dalela D, Karabon P, Sammon J, Vetterlein M, Noldus J, Peabody J, Trinh Q, Menon M, Abdollah F
CLIN GENITOURIN CANC. 2017;15(6):e955-e968.
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: Results from PROMETRICS 2011
May M, Fritsche H, Vetterlein M, Bastian P, Gierth M, Nuhn P, Aziz A, Fisch M, Stief C, Hohenfellner M, Wirth M, Novotny V, Hakenberg O, Noldus J, Gilfrich C, Bolenz C, Burger M, Brookman-May S
WORLD J UROL. 2017;35(2):245-250.
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database
May M, Protzel C, Vetterlein M, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm M, Nuhn P, Bastian P, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg O
INT UROL NEPHROL. 2017;49(2):247-254.
Fühlen sich Chirurgen gerüstet für die komplexen Fragestellungen im Umgang mit multiresistenten Erregern? – Ergebnisse der Fragebogenstudie MR2
May M, Spachmann P, Lebentrau S, Schumacher H, Gilfrich C, Fritsche H, Vetterlein M, Brookman-May S, Schostak M, Wagenlehner F, Burger M, Novotny A, Obermaier R
ZBL CHIR. 2017;142(3):297-305.
Wie werden der 10-Punkte-Plan des Deutschen Bundesministeriums für Gesundheit zur Bekämpfung resistenter Erreger und Maßnahmen des Antibiotic Stewardship wahrgenommen?: Eine fachübergreifende Analyse der Kenntnis deutscher Klinikärzte und Entwicklung einer urologischen Handlungsanweisung
May M, Vetterlein M, Wagenlehner F, Brookman-May S, Gilfrich C, Fritsche H, Spachmann P, Burger M, Schostak M, Lebentrau S
UROLOGE. 2017;56(10):1302-1310.
Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017
Pradère B, Thibault C, Vetterlein M, Leow J, Peyronnet B, Rouprêt M, Seisen T
TRANSL ANDROL UROL. 2017;6(6):1049-1059.
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma
Rink M, Engel O, Gakis G, Fritsche H, Vetterlein M, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat S, Fisch M, Gild P
UROL ONCOL-SEMIN ORI. 2017;35(12):671.e17-671.e23.
An Undissolved Urological Myth – Health-Related Quality of Life after Radical Cystectomy
Rink M, Vetterlein M
SIU Academy. 2017.
The T-plasty as therapy for recurrent bladder neck stenosis: success rate, functional outcome, and patient satisfaction
Rosenbaum C, Dahlem R, Maurer V, Kluth L, Vetterlein M, Fisch M, Schuettfort V, Reiss C
WORLD J UROL. 2017;35(12):1907-1911.
Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma
Seisen T, Jindal T, Karabon P, Sood A, Bellmunt J, Leow J, Vetterlein M, Sun M, Alanee S, Choueiri T, Trinh Q, Menon M, Abdollah F
EUR UROL. 2017;71(5):714-718.
Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma
Seisen T, Krasnow R, Bellmunt J, Rouprêt M, Leow J, Lipsitz S, Vetterlein M, Preston M, Hanna N, Kibel A, Sun M, Choueiri T, Trinh Q, Chang S
J CLIN ONCOL. 2017;35(8):852-860.
Risk Assessment in Small Renal Masses: A Review Article
Sun M, Vetterlein M, Harshman L, Chang S, Choueiri T, Trinh Q
UROL CLIN N AM. 2017;44(2):189-202.
Zwischenergebnisse der PROMETRICS 2011 nach fünf Jahren
Vetterlein M, Aziz A, May M, Bastian P
Uro-News. 2017 [Epub ahead of print];21(4):37-41.
Facing the Fate of the Remnant Urothelium After Radical Cystectomy: There Is Room for Improvement
Vetterlein M, Chun F, Kluth L
EUR UROL. 2017;71(4):558-559.
Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer
Vetterlein M, Löppenberg B, Karabon P, Dalela D, Jindal T, Sood A, Chun F, Trinh Q, Menon M, Abdollah F
CANCER-AM CANCER SOC. 2017;123(17):3241-3252.
Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort
Vetterlein M, Meyer C, Leyh-Bannurah S, Mayr R, Gierth M, Fritsche H, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian P, Gilfrich C, May M, Rink M, Chun F, Dahlem R, Fisch M, Aziz A
CLIN GENITOURIN CANC. 2017;15(5):e809-e817.
Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
Vetterlein M, Roschinski J, Gild P, Marks P, Soave A, Doh O, Isbarn H, Höppner W, Wagner W, Shariat S, Brausi M, Büscheck F, Sauter G, Fisch M, Rink M
TRANSL ANDROL UROL. 2017;6(6):1018-1026.
Resident Involvement in Radical Inguinal Orchiectomy for Testicular Cancer Does Not Adversely Impact Perioperative Outcomes - A Retrospective Study
Vetterlein M, Seisen T, Löppenberg B, Hanna N, Cheng P, Fisch M, Chun F, Kibel A, Preston M, Meyer C
UROL INT. 2017;98(4):472-477.
30-Day Adverse Events Following Cystectomy for Bladder Cancer Versus Benign Bladder Conditions
Vetterlein M, Seisen T, Speed J, Friedlander D, Meyer C, Kibel A, Menon M, Fisch M, Chun F, Sun M, Eswara J, Trinh Q
Urol Pract. 2017;4(5):388-394.
Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology
Vetterlein M, Wankowicz S, Seisen T, Lander R, Löppenberg B, Chun F, Menon M, Sun M, Barletta J, Choueiri T, Bellmunt J, Trinh Q, Preston M
CANCER-AM CANCER SOC. 2017;123(22):4346-4355.
The Effect of Resident Involvement on Surgical Outcomes for Common Urologic Procedures: A Case Study of Uni- and Bilateral Hydrocele Repair
Löppenberg B, Cheng P, Speed J, Cole A, Vetterlein M, Kibel A, Noldus J, Trinh Q, Meyer C
UROLOGY. 2016;94:70-6.
Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies
Vetterlein M, Jindal T, Becker A, Regier M, Kluth L, Tilki D, Chun F
Investig Clin Urol. 2016;57(4):231-9.
Androgenentzugstherapie und Risiko für venöse Thrombembolien
Vetterlein M, Schmid M, Trinh Q, Chun F
Urologie Scan. 2016;03(04):266-267.
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis
Vetterlein M, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche H, Burger M, Novotny V, Froehner M, Wirth M, Protzel C, Hakenberg O, Roghmann F, Palisaar R, Noldus J, Pycha A, Bastian P, Trinh Q, Xylinas E, Shariat S, Rink M, Chun F, Dahlem R, Fisch M, Aziz A
EUR UROL FOCUS. 2016.
Corrigendum: Inpatient hypospadias care: Trends and outcomes from the American nationwide inpatient sample
Meyer C, Sukumar S, Sood A, Hanske J, Vetterlein M, Elder J, Fisch M, Trinh Q, Friedman A
Korean J Urol. 2015;56(9):670.
Inpatients hypospadias care: trends and outcomes from the American nationwide inpatient sample
Meyer C, Sukumar S, Sood A, Hanske J, Vetterlein M, Elder J, Fisch M, Trinh Q, Friedman A
Korean J Urol. 2015;56(8):594-600.
Letzte Aktualisierung aus dem FIS: 30.10.2024 - 23:48 Uhr